Simple, transparent pricing.

Travel and accommodation are not included in the base cost of treatment.

We administer 300 million culturally expanded umbilical cord tissue-derived mesenchymal stem cells (MSCs)

Adherence to the cGMP regulations assures the identity, strength, quality, and purity of drug/biologic products by requiring that our partner lab in the United States adequately controls manufacturing operations.

Cell viability refers to the number of live, healthy cells in a sample. Cell viability assays are used to measure the physical and physiological health of cells in response to extracellular stimuli and ensure every patient receives the same dosage (300m MSCs).

A Certificate of Analysis (COA) is a document that communicates the results of scientific tests done on the cells prior to infusion. The COA is created to ensure all important regulations are met and complied with.

As a global leader focused on translational aspects of developing cell-based therapeutics, advancing scientific research into innovative treatments for patients. We ensure that MSCs should have ≥95% surface marker expression.

Our cell product is manufactured in the United States in an FDA compliant GMP lab.  The cells undergo rigorouns third party safety and efficacy testing prior to being shipped to the Cayman Island.